Get informed when a big investor buys or sells
+ FollowOvervalued by 22.9% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $1.26 Billion |
|---|---|
| Enterprise Value | $735.24 Million |
| Annual dividend | $0.42 |
| Dividend yield | 3.17% |
| Earnings per Share | $3.29 |
| Beta | 0.32 |
| Outstanding Shares | 101,124,000 |
| P/E Ratio | 32.64 |
|---|---|
| PEG | 48.52 |
| Price to Sales | 0.78 |
| Price to Book Ratio | 1.04 |
| Enterprise Value to Revenue | 0.45 |
| Enterprise Value to EBIT | 1.23 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in Stockholm, is dedicated to the worldwide development, marketing, and distribution of probiotic products renowned for their scientifically proven health advantag...